Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Lee, Doo, Hyun; Luo, Lin; Dubin, Adrienne; Chaplan, Sandra; Brown, Sean; Liu, Changlu; Guo, Hong-Qing

Agent Shelston IP

Pub. Number AU-B-2002305809

PCT Number PCT/US02/17553

PCT Pub. Number WO2002/100328

Priority 60/347,945 07.11.01 US; 60/373,012 16.04.02 US; 60/297,108 08.06.01 US

Filing date 30 May 2002

Wipo publication date 23 December 2002

Acceptance publication date 6 December 2007

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/195 (2006.01)

A61K 31/197 (2006.01)

A61K 31/4166 (2006.01)

A61K 31/4168 (2006.01)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 49/00 (2006.01) Preparations for testing

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system